COVID Didn’t Seem to Slow Down FDA Drug Approvals

While COVID-19 has impacted almost every facet of our lives over the last few years, one area that it didn’t seem to have a huge impact on is drug approvals by the United States Food and Drug Administration (FDA). Average review time in the United States did not decrease either during the pandemic nor in the early months following the re-opening of…
Read More...

Recent Articles

Budget Increase for the FDA in 2023?

In March 2022, United States President Joe Biden released his budget request for Fiscal Year 2023, which included a significant boost for the United States Food and Drug Administration (FDA) – an…
Compliance Update

FDA

CME

CMS

Subscribe To Our Daily News

Sign up here to get the latest news and updates delivered directly to your inbox.

I agree to be emailed to confirm my subscription to this list

Discount Banner
May 2022
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Congress

Drug Prices

Open Payments

Pharmaceutical and Device